Vanguard Fiduciary Trust
UTHR icon

Vanguard Fiduciary Trust’s United Therapeutics UTHR Stock Holding History

Vanguard Fiduciary Trust’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$145M Buy
268,477
+499
+0.2% +$281K 0.03% 421
2026
Q1 		$159M Buy
+267,978
New +$133M 0.04% 371

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Vanguard Fiduciary Trust's UTHR Position: Q2 2026 in Review

Vanguard Fiduciary Trust increased its United Therapeutics (UTHR) stake by 0.19% in Q2 2026, buying an estimated $281K and bringing the position to 268,477 shares worth $145M. The position accounts for 0.03% of the portfolio, ranked #421.

Vanguard Fiduciary Trust first reported a position in UTHR in Q1 2026 and has held it in 2 quarters since. The position peaked at $159M in Q1 2026. 870 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Vanguard Fiduciary Trust held 268,477 shares of United Therapeutics worth $145M as of Q2 2026.
  • Vanguard Fiduciary Trust bought 499 United Therapeutics shares in Q2 2026, an estimated $281K.
  • United Therapeutics made up 0.03% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #421 holding.
  • Vanguard Fiduciary Trust first reported a position in United Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Fiduciary Trust's United Therapeutics position peaked at $159M in Q1 2026.
  • 870 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.